Cardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranolol
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/10942 |
Resumo: | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Investigação Cardiovascular. Rio de Janeiro, RJ, Brasil. |
id |
CRUZ_6c3d0282e269f7229b03442a95621bb4 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/10942 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Freitas, FelipeEstato, VanessaLessa, Marcos A.Tibiriça, Eduardo2015-06-22T12:26:39Z2015-06-22T12:26:39Z2014FREITAS, Felipe et al. Cardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranolol. Fundamental & Clinical Pharmacology, v.29 , p.31-40, 2015.1472-8206https://www.arca.fiocruz.br/handle/icict/1094210.1111/fcp.12075engWiley Online LibraryCardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranololinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Investigação Cardiovascular. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Investigação Cardiovascular. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Investigação Cardiovascular. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Investigação Cardiovascular. Rio de Janeiro, RJ, Brasil.Cardiac microvascular rarefaction appears to be involved in hyperthyroidisminduced left ventricular hypertrophy and dysfunction. We investigated the effects of losartan, an AT1 receptor antagonist; diltiazem, a calcium channel blocker; and propranolol, a b-adrenergic receptor antagonist, on cardiac function and structural microcirculatory cardiac alterations in an experimental model of L-thyroxininduced hyperthyroidism in rats. Hyperthyroidism (HYPER) was induced by intraperitoneal injections of L-thyroxin for 35 days (600 lg/kg/day; n = 32). The euthyroid group was treated with distilled water (EUT + VEH; n = 8). On the 14th day, the HYPER group was divided into four groups that received an oral treatment for 21 days with saline (HYPER + VEH; n = 8), losartan (10 mg/kg/day; HYPER + LOS, n = 8), diltiazem (10 mg/kg/day; HYPER + DILT, n = 8), or propranolol (10 mg/kg/day; HYPER + PROP, n = 8). An echocardiographic study was performed at baseline, at the beginning and at the end of the pharmacological treatment protocol (35th day). The structural capillary density in the left ventricle (LV) was analyzed using histochemical analysis with fluorescein isothiocyanateconjugated Griffonia simplicifolia lectin. HYPER + VEH (182 5 mmHg; P < 0.001) presented higher systolic blood pressure (SBP) compared with EUT + VEH (132 3 mmHg). HYPER + LOS (144 2 mmHg), HYPER + DILT (147 3 mmHg) and HYPER + PROP (153 4 mmHg) presented lower SBP compared with HYPER + VEH (P < 0.001). Chronic treatment with losartan, diltiazem, and propranolol reversed cardiac structural microvascular rarefaction (HYPER + VEH 0.16 0.01; EUT + VEH 0.35 0.02; HYPER + LOS 0.46 0.03; HYPER + DILT 0.49 0.02; HYPER + PROP 0.58 0.04 (Vv [cap]/Vv[fib]); P < 0.001) and enhanced the LV ejection fraction of hyperthyroid rats (HYPER + VEH 71 3; EUT + VEH 85 2; HYPER + LOS 90 3; HYPER + DILT 85 3; HYPER + PROP 86 2%; P < 0.05). In conclusion, chronic treatment with losartan, diltiazem, and propranolol improved the cardiac microcirculation and function in an experimental model of hyperthyroidism in rats.Capillary densityCardiac hypertrophyCardiac microvascularRarefactionHyperthyroidismCardiomegaliaHipertireodismoAção Capilarinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1914https://www.arca.fiocruz.br/bitstream/icict/10942/1/license.txt7d48279ffeed55da8dfe2f8e81f3b81fMD51ORIGINALfelipe_freitaseta_IOC_2014.pdfapplication/pdf561421https://www.arca.fiocruz.br/bitstream/icict/10942/2/felipe_freitaseta_IOC_2014.pdfb11dc0d457f8279a779dac4a694b63e5MD52TEXTfelipe_freitaseta_IOC_2014.pdf.txtfelipe_freitaseta_IOC_2014.pdf.txtExtracted texttext/plain44255https://www.arca.fiocruz.br/bitstream/icict/10942/3/felipe_freitaseta_IOC_2014.pdf.txtd4ab6d23cfa81c71603d4f8cc802f460MD53icict/109422022-06-24 13:03:05.596oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-06-24T16:03:05Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Cardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranolol |
title |
Cardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranolol |
spellingShingle |
Cardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranolol Freitas, Felipe Capillary density Cardiac hypertrophy Cardiac microvascular Rarefaction Hyperthyroidism Cardiomegalia Hipertireodismo Ação Capilar |
title_short |
Cardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranolol |
title_full |
Cardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranolol |
title_fullStr |
Cardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranolol |
title_full_unstemmed |
Cardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranolol |
title_sort |
Cardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranolol |
author |
Freitas, Felipe |
author_facet |
Freitas, Felipe Estato, Vanessa Lessa, Marcos A. Tibiriça, Eduardo |
author_role |
author |
author2 |
Estato, Vanessa Lessa, Marcos A. Tibiriça, Eduardo |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Freitas, Felipe Estato, Vanessa Lessa, Marcos A. Tibiriça, Eduardo |
dc.subject.en.pt_BR.fl_str_mv |
Capillary density Cardiac hypertrophy Cardiac microvascular Rarefaction Hyperthyroidism |
topic |
Capillary density Cardiac hypertrophy Cardiac microvascular Rarefaction Hyperthyroidism Cardiomegalia Hipertireodismo Ação Capilar |
dc.subject.decs.pt_BR.fl_str_mv |
Cardiomegalia Hipertireodismo Ação Capilar |
description |
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Investigação Cardiovascular. Rio de Janeiro, RJ, Brasil. |
publishDate |
2014 |
dc.date.issued.fl_str_mv |
2014 |
dc.date.accessioned.fl_str_mv |
2015-06-22T12:26:39Z |
dc.date.available.fl_str_mv |
2015-06-22T12:26:39Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
FREITAS, Felipe et al. Cardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranolol. Fundamental & Clinical Pharmacology, v.29 , p.31-40, 2015. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/10942 |
dc.identifier.issn.pt_BR.fl_str_mv |
1472-8206 |
dc.identifier.doi.pt_BR.fl_str_mv |
10.1111/fcp.12075 |
identifier_str_mv |
FREITAS, Felipe et al. Cardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranolol. Fundamental & Clinical Pharmacology, v.29 , p.31-40, 2015. 1472-8206 10.1111/fcp.12075 |
url |
https://www.arca.fiocruz.br/handle/icict/10942 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Wiley Online Library |
publisher.none.fl_str_mv |
Wiley Online Library |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/10942/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/10942/2/felipe_freitaseta_IOC_2014.pdf https://www.arca.fiocruz.br/bitstream/icict/10942/3/felipe_freitaseta_IOC_2014.pdf.txt |
bitstream.checksum.fl_str_mv |
7d48279ffeed55da8dfe2f8e81f3b81f b11dc0d457f8279a779dac4a694b63e5 d4ab6d23cfa81c71603d4f8cc802f460 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1798324957007052800 |